The Cancer Risk Evaluation Program at the Joan Karnell Cancer Center
About the Center | Programs & Treatments | Supportive Care | Clinical Research | Resources
 
Programs and Treatments
Bloodless Medicine & Surgery
Cancer Risk Evaluation Program

What Sets Us Apart?

Assessing Your Risk for Hereditary Cancer

Breast & Ovarian
Cancer Risk

Gastrointestinal Cancer Risk

Sarcoma Risk Assessment Program

Research

Suggested Resources
Geriatric Oncology
GYN Oncology
HIV Oncology Program
Inpatient Oncology
Integrated Breast Center
Medical Oncology
Pathology Services
Post-treatment Services
Radiation Oncology
Radiology Services
Sarcoma Program
Second Opinion
Stem Cell Transplant Program
Surgical Oncology
 
<< Back to ACC at PAH home page
 

Participation in Familial Research

Pennsylvania Hospital is part of Penn Medicine and has a collaborative research affiliation with the University of Pennsylvania’s Abramson Cancer Center. Your participation in the Cancer Risk Evaluation Program at Pennsylvania Hospital also may present an opportunity to participate in research evaluating yet undiscovered genetic and environmental causes of cancer.

This research is working to better understand the role of genetics in cancer development. The primary investigators in this research at Penn’s Abramson Cancer Center are Susan Domchek, MD, and Katherine Nathanson, MD. This research may involve studies of chemoprevention, genetics, and clinical screening.

 

 

 

 

 

 

 


appointment icon

Need an appointment? Request one online 24 hours/day, 7 days/week or call 800-789-PENN (7366) to speak to a referral counselor.

Related Links
Find a Cancer Specialist
Request an Appointment Online or call
800-789-PENN (7366)
Pennsylvania Hospital Visitor Information
Give Now to JKCC
Encyclopedia Articles about Cancer

 

   
   

 

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2014, The Trustees of the University of Pennsylvania space